SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-068221
Filing Date
2021-12-06
Accepted
2021-12-06 21:01:07
Documents
1
Period of Report
2021-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 29020
  Complete submission text file 0001209191-21-068221.txt   30406
Mailing Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451
Business Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451 617-715-3600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address HALOZYME THERAPEUTICS, INC. 11588 SORRENTO VALLEY ROAD, #17 SAN DIEGO CA 92121
Business Address
RAMSAY DAVID A (Reporting) CIK: 0001283292 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36282 | Film No.: 211474498